Article Abstract

Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint

Authors: Taizo Hibi, Yasuhiko Sugawara


The role of bridging locoregional therapy (LRT) for patients with hepatocellular carcinoma (HCC) within Milan criteria before liver transplantation (LT) has been controversial. Recently, Agopian et al. (1) retrospectively investigated the impact of bridging LRT on post-LT HCC recurrence and survival based on 3,601 patients undergoing LT from 2002 to 2013, collected in the US Multicenter HCC Transplant Consortium.